Tech Company Financing Transactions
Nootrobox Funding Round
Nootrobox closed a $2 million funding round on 12/4/2015. Investors included Andreessen Horowitz and private investors.
Transaction Overview
Company Name
Announced On
12/4/2015
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Andreessen Horowitz (Lead Investor) (Christopher Dixon)
Proceeds Purpose
The new capital will allow us to accelerate clinical research and development on nootropics, to double down on our manufacturing and supply chain innovation, and to continue building a world class team across all disciplines of medicine, software, and product manufacturing.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
171 2nd St. 6th Floor
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Nootropics describe a broad classification compounds with cognitive enhancing properties with minimal side-effects and appropriate for long-term use. We understand that human understanding and research behind nootropics, cognitive modulation, and broader biohacking is constantly evolving and improving.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Geoffrey Woo
Chief Operating Officer
Michael Brandt
Browse more venture capital transactions:
Prev: 12/4/2015: Autonomic Materials venture capital transaction
Next: 12/4/2015: 3PL Central venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs